IMGN - ImmunoGen Inc. (IMGN) CEO Mark Enyedy on Q3 2020 Results - Earnings Call Transcript

ImmunoGen, Inc. (IMGN) Q3 2020 Earnings Conference Call November 06, 2020, 08:00 AM ET Company Participants Courtney O'Konek - Senior Director, Corporate Communications and IR Mark Enyedy - President and CEO Susan Altschuller - CFO Anna Berkenblit - Chief Medical Officer Conference Call Participants John Newman - Canaccord Michael Schmidt - Guggenheim Andy Hsieh - William Blair & Company Biren Amin - Jefferies Jessica Fye - JP Morgan Boris Peaker - Cowen Joe Catanzaro - Piper Sandler David Ruch - SVB Leerink Kennen MacKay - RBC Presentation Operator Good morning, and welcome to ImmunoGen's Third Quarter 2020 Financial and Operating Results Conference Call. Today's conference is being recorded. Now I'd like to turn the call over to Courtney O'Konek, Senior Director of Corporate Communications and Investor Relations. Please go ahead. Courtney O'Konek Good morning and thank you for joining today's call. Earlier today, we issued a press release that includes

For further details see:

ImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q3 2020 Results - Earnings Call Transcript